Robert Koch

German bacteriologist and 1905 Nobel laureate known for research on anthrax, tuberculosis and cholera.

In brief

His biography spans medical training, laboratory methods, infection research, therapeutic controversies and a specific connection to occupational biological hazards.

Contents
  1. Who was Robert Koch
  2. Early life and education in Göttingen
  3. From medical practice to the laboratory
  4. Anthrax and early publications
  5. Culture, microscopy and teamwork
  6. Tuberculosis: the 1882 announcement and paper
  7. What Koch’s postulates address
  8. Cholera, water and sharing knowledge
  9. Professor of hygiene and institute director
  10. Tuberculin and its limitations
  11. Expeditions and ethical controversy
  12. Nobel Prize, foundation and legacy
  13. Anthrax risks in work with animals and animal products
  14. Related content
  15. References

Personalities →

Who was Robert Koch

Robert Koch was a German physician and bacteriologist central to the development of medical microbiology. He investigated anthrax, tuberculosis and cholera, combining microscopy, culture and experimentation to connect particular microorganisms with diseases. [9] He received the 1905 Nobel Prize in Physiology or Medicine for his tuberculosis research. [16]

Early life and education in Göttingen

Born on 11 December 1843 in Clausthal in the Harz region, he studied natural sciences and medicine in Göttingen between 1862 and 1866. In 1865 he won an academic prize for research on nervous-system anatomy and became an assistant at the pathological museum. He completed his doctorate in 1866 before beginning clinical practice. [5]

From medical practice to the laboratory

He practised in several towns and served in a field hospital during the 1870–1871 Franco-Prussian War. From 1872 to 1880 he was district physician in Wollstein, now Wolsztyn in Poland. He joined Berlin’s Imperial Health Office in 1880, gaining resources for research and collaboration with other bacteriologists. [6]

Anthrax and early publications

In Wollstein he investigated anthrax microscopically alongside medical practice. His 1876 work connected the bacillus’s life cycle with disease and brought scientific recognition. The advance was an experimental account of infection that linked the observed organism to the pathological process, extending beyond descriptions of symptoms. [7]

In 1878 he published Untersuchungen über die Aetiologie der Wundinfectionskrankheiten on wound-infection aetiology. He used animal models to investigate processes resembling those observed in people. The book reflects his emphasis on experimentally distinguishing diseases and agents; these models were not themselves clinical evidence for a human treatment. [8]

Culture, microscopy and teamwork

Solid media and staining helped researchers separate and observe bacteria. Koch’s colleague Julius Richard Petri developed the dish bearing his name. [9] Fanny Angelina Hesse introduced agar into the laboratory; American Society for Microbiology archives have recovered documents on her contribution. These tools’ history includes achievements that should not be credited to Koch alone. [10]

Tuberculosis: the 1882 announcement and paper

On 24 March 1882 he announced identification of the tuberculosis agent to the Berlin Physiological Society. His paper Die Aetiologie der Tuberculose appeared in Berliner Klinische Wochenschrift on 10 April. These dates distinguish the public announcement from the printed record of his research on the bacillus now called Mycobacterium tuberculosis. [11]

What Koch’s postulates address

The postulates connect agent and disease through consistent association, isolation and experimental reproduction. Their value lies in demanding causal evidence. Limitations include organisms that cannot grow independently and symptom-free infection. In 1996 Fredricks and Relman proposed molecular sequence-based criteria to extend this assessment while retaining the need for concordant, reproducible evidence. [12]

Cholera, water and sharing knowledge

His 1883–1884 expeditions to Egypt and India investigated cholera. [2] A contemporary account records his presentation of specimens and microscopic observations to other physicians. [14] Historical priority belongs to Filippo Pacini, who described the vibrio in 1854, thirty years before Koch’s investigation, as documented by WHO. [13]

Training spread his methods. George W. Lewis described courses organised in Berlin between October 1884 and January 1885, with small groups of physicians attending ten-day sessions. They combined explanations of cholera with practical detection and culture work. Sharing these techniques helped bacteriology expand. [19]

During Hamburg’s 1892 epidemic he intervened as a government representative and highlighted water-supply deficiencies. Neighbouring Altona already used sand filtration and suffered a much smaller epidemic. Municipal records place this comparison within the subsequent construction of the Kaltehofe filters, connecting microbiological research and health infrastructure. [17]

Professor of hygiene and institute director

In 1885 he became professor of hygiene at Berlin University and director of its institute and museum. In 1891 he moved to the new Institute for Infectious Diseases, with Max Rubner succeeding him in hygiene. These were separate institutions and career stages: university work preceded leadership of the centre later named after him. [15]

Tuberculin and its limitations

In 1890 he presented a substance he hoped would combat tuberculosis. His communications described tests, reactions and therapeutic expectations, documenting his interpretation before a full assessment of outcomes. [18] Tuberculin did not achieve the hoped-for cure; its later use shifted towards diagnosing infection. [1]

Expeditions and ethical controversy

He investigated rinderpest in South Africa and malaria in Italy and New Guinea. He retired as institute director in 1904 but continued research. [2]

The RKI considers his 1906–1907 sleeping-sickness experiments in East Africa ethically unacceptable. Atoxyl treatment caused harm, including blindness. This colonial period forms part of the critical reassessment of his legacy. [3]

Nobel Prize, foundation and legacy

The 1905 Nobel Prize specifically recognised his tuberculosis investigations and discoveries. [16] The Robert Koch Foundation was established in 1907 to support research into that disease. Koch served on its board and received research funding in 1909, linking recognition of his work with support for further investigation of infections. [20]

He died in Baden-Baden on 27 May 1910; his ashes were placed in a mausoleum at the institute. [2]

Anthrax risks in work with animals and animal products

A concrete occupational-health connection starts with Koch’s investigations of anthrax and Bacillus anthracis spores.[1] NIOSH documents occupational exposures associated with contact with contaminated animals or animal products, including wool, hides and hair.[4]

The link is the progression from an observed disease to identification of an agent and materials capable of carrying it.

In an activity processing these materials, the preventive question varies with the task: receiving raw materials, opening containers, handling products and cleaning an area do not necessarily describe the same exposure. As an application for reading this case, the material’s route and the people involved should be reconstructed rather than relying on the industry’s name alone.

Koch contributed bacteriological knowledge for hazard identification.[1]

Contemporary assessment and control programmes develop that scientific foundation around the materials, tasks and people involved in each activity.

  • Health. His preventive connection concerns the foundations of biological-agent research. A complete reading combines hazard identification and experimental rigour with protection of people: scientific achievement does not remove responsibility for the methods used.

References

  1. Robert Koch Institute. Robert Koch: One of the founders of microbiology
  2. Robert Koch Institute. Robert Koch’s Curriculum Vitae
  3. Robert Koch Institute. Dealing with the colonial legacy at the RKI
  4. National Institute for Occupational Safety and Health / CDC. Anthrax in the Workplace. Accessed: 2026-11-07.
  5. Universitätsverlag Göttingen. Das Göttinger Nobelpreiswunder: Robert Koch. Accessed: 2026-11-08.
  6. Deutsches Historisches Museum. Robert Koch, 1843–1910. Accessed: 2026-11-08.
  7. University of Alabama at Birmingham, Reynolds-Finley Historical Library. Koch, Robert: Medical Greats. Accessed: 2026-11-08.
  8. Robert Koch Institute. Krankheit aus dem Labor: Untersuchungen über die Aetiologie der Wundinfectionskrankheiten. Accessed: 2026-11-08.
  9. Science Museum Group. Robert Koch. Accessed: 2026-11-08.
  10. Center for the History of Microbiology / University of Maryland Baltimore County. ASM Archives: Microbe 2025, Fanny Angelina Hesse. Accessed: 2026-11-08.
  11. Robert Koch / Deutsches Historisches Museum. Die Aetiologie der Tuberculose, 1882. Accessed: 2026-11-08.
  12. D. N. Fredricks y D. A. Relman. Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Accessed: 2026-11-08.
  13. World Health Organization, WHO Chronicle 1974. Filippo Pacini and the cholera vibrio. Accessed: 2026-11-08.
  14. Conferencia contemporánea de Koch, traducción S. Pollak. Cholera Researches of Dr. Koch. Accessed: 2026-11-08.
  15. Humboldt-Universität zu Berlin. Hygienemuseum. Accessed: 2026-11-08.
  16. Nobel Foundation. The Nobel Prize in Physiology or Medicine 1905. Accessed: 2026-11-08.
  17. Freie und Hansestadt Hamburg, Denkmalschutzamt. William Lindley: Infrastruktur und Cholera 1892. Accessed: 2026-11-08.
  18. Robert Koch. A Further Communication on a Remedy for Tuberculosis. Accessed: 2026-11-08.
  19. George W. Lewis Jr.. Dr. Koch’s Cultivation Experiments in Cholera Bacillus. Accessed: 2026-11-08.
  20. Robert Koch Foundation. Portrait of Robert Koch. Accessed: 2026-11-08.

Editorial information

Publication date: 7 November 2026.

Editorial Manager: Sabentis Editorial Team.

Pablo Rodríguez

Editorial review by Pablo RodríguezLinkedIn

Executive Vice President of the International ORP Foundation and Chief Financial Officer of Sabentis.

Request a Demo

Discover all that Sabentis can do for your organization.

Try Sabentis

request a demo
stars 5
GetApp Software Advice Capterra